Pith. sign in

REVIEW 4 major objections 4 minor 24 references

X-ray resonance therapy with parametric X-ray radiation (PXR) for sulfur-containing tumor tissues

T0 review · 4 major / 4 minor · reviewed 2026-08-04 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read The paper claims PXR tuned to the sulfur K-edge can selectively ionize sulfur atoms in superficial tumors, delivering about 1.3 Gy versus 100 times more from a conventional X-ray tube.

desk verdict PXR for sulfur K-edge is a plausible new application, but the dose estimate uses the wrong volume and the central comparison to X-ray tubes collapses. read the letter →

arxiv 2510.03652 v2 pith:RELCSPEG submitted 2025-10-04 physics.bio-ph

N. Q. San , O. D. Skoromnik , A. U. Leonau , V. Q. Nha , I. D. Feranchuk This is my paper · ORCID
classification physics.bio-ph PACS 41.59.+h82.59.-m87.59.-e
keywords parametricX-rayradiationsulfurK-edgeresonantphotoionizationselectivecancertherapydosesuperficialtumorsmedicalaccelerators
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper sets out to show that parametric X-ray radiation (PXR) — X-rays produced when electrons pass through a crystal — can be tuned to the 2.4 keV K-absorption edge of sulfur and serve as a selective therapy for superficial sulfur-containing tumors. Since tumor cells carry roughly three times more sulfur than healthy cells, resonant absorption by sulfur atoms should damage tumors preferentially. The authors estimate a PXR source delivers about 1.3 Gy for a 600-second session, while a conventional X-ray tube needs about 100 times that dose for the same effect. If correct, this makes selective resonance therapy possible with compact 20–40 MeV medical accelerators.

What carries the argument

The mechanism is resonant photoionization at the sulfur K-edge driven by parametric X-ray radiation. PXR is generated when an electron bunch passes through a crystal; its spectral peak is set by crystal orientation via sinθ_B = πc/(dω_K), and its bandwidth and divergence scale as γ⁻¹. This gives a tunable, quasi-monochromatic X-ray source whose frequency matches the sulfur absorption line. The selectivity is quantified by K(D) ≈ 3, reflecting the threefold higher sulfur concentration in tumor cells.

What would settle it

Measure the dose-depth profile of a 2.4 keV PXR beam in a tissue-equivalent material: if the absorbed dose in a 1 cm² target of 1 mm thickness exceeds ~100 Gy over 600 s, the 1.3 Gy estimate is wrong because the volume assumption in Eq. (30) fails.

Watch

Extended reading notes

Core claim

The central claim is that PXR photons from a 25 MeV electron beam in a silicon crystal can be tuned to the sulfur K-edge at 2.4 keV by setting the crystal angle to θ_B ≈ 51.26°. Because the beam is quasi-monochromatic (Δω/ω ≈ 10⁻²) and narrow (Δθ ≈ 10⁻²), essentially only sulfur atoms absorb it. The estimated flux of ~3×10¹¹ photons per second ionizes about 3×10⁻⁴ of the sulfur atoms in a tumor after 600 s, exceeding the critical concentration for irreversible tumor damage. The total absorbed dose is then about 1.3 Gy, two orders of magnitude below the dose from a conventional X-ray tube for the same biological effect.

Load-bearing premise

The entire dose comparison hinges on the assumption that the absorbed energy spreads through a thermal-diffusion volume V ≈ 8(at)^{3/2} with a = 10⁻⁶ m²/s; if the energy stays in the much smaller X-ray penetration volume, the dose is no longer 1.3 Gy and the claimed advantage over X-ray tubes disappears.

Editorial extensions

If this is right

  • Medical accelerators in the 20–40 MeV range could act as compact PXR sources, removing the need for GeV-scale synchrotron facilities for this kind of selective therapy.
  • Superficial tumors with elevated sulfur content could be treated with an integral dose near 1 Gy, reducing collateral damage to healthy tissue.
  • The estimated PXR flux of ~3×10¹¹ ph/s exceeds the source requirement of ~10⁸ ph/s by a wide margin, giving practical headroom for beam shaping and delivery losses.
  • If the K(D) ≈ 3 selectivity holds in vivo, the therapeutic ratio for sulfur-rich tumors would be roughly three times better than for non-selective irradiation.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • One extension not made in the paper: the dose calculation in Eq. (30) uses a thermal-diffusion volume of V ≈ 8(at)^{3/2}. If instead the dose is deposited in the much smaller X-ray attenuation volume — 2.4 keV photons penetrate only about 0.1 mm in tissue — the actual absorbed dose would be far higher than 1.3 Gy, potentially hundreds of Gy. This is a testable correction, not a claim of the paper.
  • The selectivity claim implicitly assumes that sulfur K-shell ionization reliably triggers tumor-cell death; an in vitro survival assay on sulfur-rich versus normal cell lines under 2.4 keV narrow-band irradiation would directly test this.
  • A tunable PXR source could also target other biologically relevant K-edges in the 2–10 keV range, such as calcium or phosphorus, if a tumor type shows a concentration differential for those elements.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 4 minor

Summary. The paper proposes using parametric X-ray radiation (PXR) tuned to the sulfur K-edge (2.4 keV) for selective radiation therapy of superficial tumors with elevated sulfur content. It derives the required photon flux, estimates the PXR output (Nph ≈ 3e11 ph/s), and calculates the resulting ionization fraction and total absorbed dose, claiming that PXR delivers about 1.3 Gy, two orders of magnitude lower than conventional X-ray tubes.

Significance. If correct, this would be a novel, compact, and selective radiotherapy modality. The authors make a transparent analytic estimate based on published cross-sections and PXR formulas, which is a strength. However, the central dose calculation (Eq. 29–31) is physically inappropriate and reverses the claimed dose advantage. The paper also contains internal numerical inconsistencies. The manuscript therefore does not currently support its main conclusion.

major comments (4)
  1. [§IV, Eqs. (29)–(31)] The absorbed dose is computed using the thermal-diffusion volume V≈8(at)^{3/2}, but photon energy is deposited in the beam-irradiated volume, approximately ΣL. Using the paper's own numbers (ℏωK≈4e-16 J, Nph≈3e11 s^-1, t=600 s, Σ≈1 cm², L≈1 mm, ρ≈4e3 kg/m³), D = ℏωK Nph t / (ρΣL) ≈ 180 Gy, not 1.3 Gy. With a more realistic attenuation length of ~0.1 mm at 2.4 keV, the dose is even higher. Thus Eq. (31) and the claimed two-orders-of-magnitude dose reduction versus X-ray tubes are unsupported.
  2. [Eq. (7) vs. §IV] The resonant cross-section is given as σ0 ≈ 9.2×10^{-20} cm² in Eq. (7), but §IV uses σ0 ≈ 1.1×10^{-19} cm². This inconsistency affects estimates in Eqs. (26)–(28) and the flux requirement; the source of either value should be clarified and the correct value used consistently.
  3. [§IV, Eqs. (26)–(28)] The stated ionization fraction Ni ≈ 3×10^{-4} N0 does not follow from the preceding formulas. Substituting σ0 = 1.1×10^{-19} cm², Nph = 3×10^{11} s^{-1}, t = 600 s, and Σ = 1 cm² into Eq. (27) gives Ni/N0 ≈ 2×10^{-5}, an order of magnitude smaller. This does not change the qualitative conclusion because 2×10^{-5} > 10^{-7}, but the numerical claim is incorrect.
  4. [§IV, reference to 'critical concentration (23)'] The text refers to 'the critical concentration (23), N_cr_i(D)∼10^{-7}' but no Eq. (23) defines such a quantity; Eq. (23) in the manuscript is the PXR photon-rate formula. The comparison to the critical concentration is therefore unverifiable as written.
minor comments (4)
  1. [§IV, first paragraph] The assumed penetration depth L ~ 1 mm for 2.4 keV X-rays should be justified; near the sulfur K-edge, the attenuation length in tissue is typically closer to 0.1 mm. The conclusion depends on this value.
  2. [Eq. (10)] The approximation M = m_S N_S0 treats the tumor mass as pure sulfur. For real tissue this overestimates the dose for a given photon flux and should be stated as an upper-limit assumption.
  3. [General] The equation numbering is inconsistent: the text mentions 'critical concentration (23)', but Eq. (23) is the PXR intensity formula. Re-number or correct the cross-references.
  4. [Figure captions] Minor typos: 'Spectra photo-ionisation of S' and 'Scheme of the PXR generation' should be corrected, and the axis label in Fig. 2 ('σ, Mb , a.u.') is unclear.

Circularity Check

0 steps flagged · score 0.0 of 10

No circularity: the derivation is a design calculation from literature cross sections and a standard PXR yield formula, not an input-renamed prediction.

full rationale

The derivation chain is not circular. The required photon flux (Eq. 18) is obtained by choosing a therapeutic dose D=10 Gy from literature and combining it with the sulfur K-edge cross-section from external tabulations (Eqs. 5-8); this is a stated design target, not a fitted prediction. The PXR source strength Nph≈3e11 ph/s (Eq. 24) is computed from the standard PXR yield formula (Eq. 23) using crystal polarizabilities from an external database [16]; no parameter is fitted to the later dose claim. Equations (29)-(31) evaluate the absorbed dose using an assumed thermal-diffusion volume (Eq. 30); this may be a physically questionable assumption, but an incorrect or unconventional assumption is not circularity. The paper's comparison with a conventional X-ray tube is attributed to [6]; although [6] shares an author with the present paper, that comparison is an external benchmark and is not derived from the present equations. The predicted ionized sulfur fraction (Eq. 28) is compared with a literature threshold, and the threshold is not constructed from the PXR flux. No step reduces by definition to its own input.

Assumptions & free parameters 4 free parameters · 3 assumptions · 0 invented entities

The central claim rests on a chain of literature-valued inputs (cross-section, sulfur enrichment, threshold ionization fraction) plus an incorrect dose-volume model. No new entities are postulated.

free parameters (4)
  • Sulfur enrichment factor = 3
    Taken from refs [8-10] as the basis for K(D) ≈ 3; no specific tumor type or confidence interval provided (Eq. 3).
  • Therapeutic ionization threshold = NS/NS0 ≈ 1e-9 (Eq. 12) or Ncr ≈ 1e-7 (Section IV)
    Values are stated from reference [12] without derivation; the two values in the paper differ by 100x.
  • Penetration depth L = 1 mm (assumed)
    Assumed in Section IV for 2.4 keV photons; at this energy typical tissue attenuation length is about 0.1 mm, changing all dose-volume results.
  • Heat-conductivity volume scale a = 1e-6 m^2/s
    Used to define the volume in Eq. (30); this is irrelevant to radiation dose deposition and is physically misplaced.
assumptions (3)
  • domain assumption PXR yield and spectral formulas (Eqs. 19-23) are valid
    Taken from ref [4] (same group's monograph); the yield constant Nph ≈ 3e11 ph/s is not reproduced here by a derivation with stated parameters.
  • ad hoc to paper The tumor mass is approximated as pure sulfur (M = mS NS0, Eq. 10)
    This ignores the mass fraction of sulfur in tissue (~0.1-1%), distorting the dose calibration in Eqs. (9)-(12).
  • domain assumption Cell death is proportional to the number of ionized sulfur atoms
    Central to the selectivity claim; no quantitative biological mechanism is established; the paper assumes a cascade of secondary processes (Auger, characteristic radiation).

how reviews work

0 comments
Cite this review

Pith. "Pith review of X-ray resonance therapy with parametric X-ray radiation (PXR) for sulfur-containing tumor tissues." pith.science (2026). https://pith.science/paper/RELCSPEG

@misc{pith2026251003652,
  author       = {Pith},
  title        = {Pith review of: X-ray resonance therapy with parametric X-ray radiation (PXR) for sulfur-containing tumor tissues},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/RELCSPEG}},
  note         = {Machine review of arXiv:2510.03652}
}
read the original abstract

We investigate the possibility of usage of the parametric X-ray radiation (PXR) for the selective therapy of superficial sulfur-containing tumor tissues. In these tissues, the concentration of sulfur atoms is significantly higher than in healthy ones. Accordingly, the destruction of cancer cells is caused by the ionization of sulfur atoms. The selective nature of the therapy is determined by the narrow spectral-angular distribution of the PXR photon beam and the resonant absorption of radiation by sulfur atoms. This leads to a significant decrease in the total dose required to achieve the desired effects compared to irradiation with conventional X-ray tubes or electron accelerators.

Figures

Figures reproduced from arXiv: 2510.03652 by the authors.

Figure 1
Figure 1. Scheme of the PXR generation 2200 2400 2600 2800 3000 0.05 0.10 0.15 2000 σ, Mb , a.u. I I0 1.0 2.0 3.0 ħω, eV [PITH_FULL_IMAGE:figures/full_fig_p004_1.png] view at source ↗
Figure 2
Figure 2. Spectra photo-ionisation of S (solid line) and PXR (dash line) [PITH_FULL_IMAGE:figures/full_fig_p004_2.png] view at source ↗

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

24 extracted references

  1. [1]

    The source should have tunable frequency, such that the maximum of intensity was located and the absorptionK-edge of the sulphur atomℏωK = 2.4 keV

  2. [2]

    The source should emit the quasi-monochromatic X-ray radiation with the full width at half maxi- mum∆ ω ≈10 −2ωK

  3. [3]

    The spatial width of the photon beam should be around1 cm 2

  4. [4]

    The source should emit approximately∼108 pho- tons per second

  5. [5]

    In the next section, we will demonstrate that a radia- tion source based on PXR satisfies all the above require- ments

    The whole experimental setup should be compact, thus allowing its location at the ordinary hospitals. In the next section, we will demonstrate that a radia- tion source based on PXR satisfies all the above require- ments. III. PXR CHARACTERISTICS Parametric X-ray radiation (PXR) is emitted when the electron bunch moves through the crystal. This mecha- nis...

    2000

  6. [6]

    Sandoghdar, Essay: Exploring the physics of basic medical research, Phys

    V. Sandoghdar, Essay: Exploring the physics of basic medical research, Phys. Rev. Lett.132, 090001 (2024)

    2024

  7. [7]

    Y. B. Kudryashov,Radiation Biophysics (Ionizing Radi- ations)(Nova Publishers, 2008)

    2008

  8. [8]

    Labriet, C

    H. Labriet, C. Nemoz, M. Renier, P. Berkvens, T. Brochard, R. Cassagne, H. Elleaume, F. Estève, C. Verry, J. Balosso,et al., Significant dose reduction using synchrotron radiation computed tomography: first clinical case and application to high resolution ct exams, Scientific reports8, 12491 (2018)

    2018

Show all 24 references
  1. [9]

    V. G. Baryshevsky, I. D. Feranchuk, and A. P. Ulya- nenkov,Parametric X-Ray Radiation in Crystals: The- ory, Experiment and Applications (Springer Tracts in Modern Physics)(Springer, 2006)

    2006

  2. [10]

    E. B. Podgoršak, Particle accelerators in medicine, in Compendium to Radiation Physics for Medical Physi- cists: 300 Problems and Solutions(Springer Berlin Hei- delberg, Berlin, Heidelberg, 2014) pp. 1041–1099

    2014

  3. [11]

    Balanov, A

    A. Balanov, A. Gorlach, V. Baryshevsky, I. Feranchuk, H. Nitta, Y. Hayakawa, A. Shchagin, Y. Takabayashi, Y. Danon, L. J. Wong, and I. Kaminer, Coherent interac- tions of free electrons and matter: Toward tunable com- pactx-raysources(2024),arXiv:2412.15775[physics.app- ph]

    2024

  4. [12]

    Kuzin, The action of atomic radiation in low doses on the biota, Radiobiologiya31, 175 (1991), [in russian]

    A. Kuzin, The action of atomic radiation in low doses on the biota, Radiobiologiya31, 175 (1991), [in russian]

    1991

  5. [13]

    M. P. Gamcsik, M. S. Kasibhatla, S. D. Teeter, and O. M. Colvin, Glutathione levels in human tumors, Biomarkers 17, 671 (2012)

    2012

  6. [14]

    Huang, C

    Z.-Z. Huang, C. Chen, Z. Zeng, H. Yang, J. Oh, L. Chen, and S. C. Lu, Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration, The FASEB Journal15, 19 (2001)

    2001

  7. [15]

    Cellarier, X

    E. Cellarier, X. Durando, M. Vasson, M. Farges, A. Demiden, J. Maurizis, J. Madelmont, and P. Chol- let, Methionine dependency and cancer treatment, Can- cer Treatment Reviews29, 489 (2003)

    2003

  8. [16]

    Czapla, W

    J. Czapla, W. M. Kwiatek, J. Lekki, J. Dulińska-Litewka, R. Steininger, and J. Göttlicher, Chemical species of sul- fur in prostate cancer cells studied by xanes spectroscopy, Radiation Physics and Chemistry93, 154 (2013)

    2013

  9. [17]

    Yu.B.Kudryashov, V.K.Mazurik, and M.F.Lomanov,Ra- diation biophysics (ionizing radiation)(Fizmatlit, 2004) [in russian]

    2004

  10. [18]

    L. D. Landau and E. M. Lifshitz,Course of Theoret- ical Physics. Volume III. Quantum Mechanics: Non- relativistic Theory(Pergamon Press, 1977)

    1977

  11. [19]

    L. I. Mirkin,Handbook of X-ray analysis of polycrys- talline materials(Springer, 1964)

    1964

  12. [20]

    Benediktovich, I

    A. Benediktovich, I. Feranchuk, and A. Ulyanenkov,The- oretical Concepts of X-Ray Nanoscale Analysis: Theory and Applications, Springer Series in Materials Science 6 (Springer Berlin Heidelberg, 2013)

    2013

  13. [21]

    S. A. Stepanov, X-ray dynamical diffraction web server, http://x-server.gmca.aps.anl.gov/, accessed: 07-03- 2019

    2019

  14. [22]

    Chernyaev, Nuclear-physical technologies in medicine, Physics of elementary particles and atomic nuclei43, 499 (2012), [in russian]

    A. Chernyaev, Nuclear-physical technologies in medicine, Physics of elementary particles and atomic nuclei43, 499 (2012), [in russian]

    2012

  15. [23]

    Gutman, E

    G. Gutman, E. Strumban, E. Sozontov, and K. Jen- row, X-ray scalpel—a new device for targeted x-ray brachytherapy and stereotactic radiosurgery, Physics in Medicine & Biology52, 1757 (2007)

    2007

  16. [24]

    Y. I. Dudchik and N. Kolchevsky, A microcapillary lens for x-rays, Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detec- tors and Associated Equipment421, 361 (1999)

    1999

Pith tools

Reviewed August 4, 2026 · model on record in the stance chip above.